News Archives | Page 14 of 18 | 340B Matters
1
archive,paged,category,category-news,category-1,paged-14,category-paged-14,ajax_fade,page_not_loaded,,qode-title-hidden,qode-theme-ver-9.1.3,wpb-js-composer js-comp-ver-4.11.1,vc_responsive

18 Jul Statement from 340BMatters on House Congressional Oversight Hearing

340B Matters, a coalition of stakeholders interested in preserving the intent and the integrity of the 340B program, released the following statement in the wake of the today’s House congressional oversight hearing on the 340B program: 340B Matters strongly supports responsible oversight and full transparency of...

Read More

18 Jul The Hill: A drug discount program that punches above its weight

When Debbie Scott from Alabama was diagnosed with colon cancer, she had no insurance and wasn’t sure how she would pay for treatment. Fortunately, she turned to Monroe County Hospital, which participates in the 340B drug discount program. For 25 years, 340B has been helping...

Read More

13 Jul Modern Healthcare: Trump may be backing off from plan to scale down 340B

Hospital lobbying groups say they're hearing President Donald Trump may be backing off plans to scale back a federal program that requires drugmakers to give discounted products to hospitals that treat a high number of poor patients. Read More: http://www.modernhealthcare.com/article/20170712/NEWS/170719964...

Read More

02 May The Hill: A program that works exactly as intended

“If it ain’t broke, don’t fix it” might be a cliché, but when it comes to healthcare policy, it’s sage wisdom. It certainly applies to a small but critically important drug discount program with a quarter century of success at supporting safety-net health providers and...

Read More

17 Oct Drug Topics: Helping Small Organizations Meet the 340B Challenge

Complying with all the provisions of the 340B Drug Pricing Program (340B) is a complex, rigorous undertaking – even for large, well-staffed hospitals and health systems. It’s equally burdensome for facilities that are small and have limited resources such as critical access hospitals (CAHs), federally...

Read More

07 Oct Fortune: Here’s Another Threat To Affordable Drugs

Big pharma takes no prisoners. The drug industry has enraged U.S. consumers with soaring drug prices. An angry mob is at the gates and CEOs seem surprised by the outrage – even a bit insulted – that their methods have been called into question. Read More...

Read More

Want To Stay Up-To-Date On The Latest 340B News?